ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Ophthalmology

Top Ophthalmology Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LES SIEGEL M.D.

Ophthalmology

5,344

$345K

861
755 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 56%

$65
Average prescription price

Avg: $72

DANNY WANG M.D.

Ophthalmology

5,068

$329K

836
749 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 56%

$65
Average prescription price

Avg: $72

KENYON KENDALL D.O.

Ophthalmology

4,918

$303K

911
830 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 56%

$62
Average prescription price

Avg: $72

NOSSONAL KLEINFELDT MD

Ophthalmology

4,684

$465K

1073
967 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

78%
prescriptions for brand name drugs

Avg: 56%

$99
Average prescription price

Avg: $72

KEVIN LAVERY MD

Ophthalmology

4,590

$311K

925
828 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 56%

$68
Average prescription price

Avg: $72

JEFFREY WENTZLOFF M.D.

Ophthalmology

4,404

$272K

831
751 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 56%

$62
Average prescription price

Avg: $72

JOHN OGRADY MD

Ophthalmology

4,215

$271K

698
587 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 56%

$64
Average prescription price

Avg: $72

MARK KINZIGER MD

Ophthalmology

3,925

$174K

814
681 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 56%

$44
Average prescription price

Avg: $72

EMAD NAKKASH MD

Ophthalmology

3,895

$367K

651
503 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

77%
prescriptions for brand name drugs

Avg: 56%

$94
Average prescription price

Avg: $72

JOSEPH HOSNER M.D.

Ophthalmology

3,892

$259K

576
522 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 56%

$67
Average prescription price

Avg: $72

NAUMAN IMAMI M.D.

Ophthalmology

3,803

$275K

546
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 56%

$72
Average prescription price

Avg: $72

KENNETH OTTO MD

Ophthalmology

3,782

$209K

811
729 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 56%

$55
Average prescription price

Avg: $72

DANIEL HADDAD M.D.

Ophthalmology

3,734

$255K

599
563 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 56%

$68
Average prescription price

Avg: $72

STEPHEN HIGGINS MD

Ophthalmology

3,484

$265K

685
646 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

74%
prescriptions for brand name drugs

Avg: 56%

$76
Average prescription price

Avg: $72

GEORGE LESSER MD

Ophthalmology

3,456

$230K

495
464 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

56%
prescriptions for brand name drugs

Avg: 56%

$67
Average prescription price

Avg: $72

JOHN ARENDSHORST M.D.

Ophthalmology

3,393

$140K

804
755 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 56%

$41
Average prescription price

Avg: $72

RICHARD WATNICK MD

Ophthalmology

3,348

$239K

549
507 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 56%

$71
Average prescription price

Avg: $72

WALTER CUKROWSKI MD

Ophthalmology

3,337

$210K

757
586 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 56%

$63
Average prescription price

Avg: $72

MARCUS MUALLEM MD

Ophthalmology

3,288

$173K

576
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 56%

$53
Average prescription price

Avg: $72

JOHN OLTEAN DO

Ophthalmology

3,285

$176K

723
624 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 56%

$54
Average prescription price

Avg: $72

ERIC SNYDER M.D.

Ophthalmology

3,279

$166K

763
695 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 56%

$51
Average prescription price

Avg: $72

MARC SIEGEL M.D.

Ophthalmology

3,277

$195K

590
506 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

52%
prescriptions for brand name drugs

Avg: 56%

$60
Average prescription price

Avg: $72

MARSHALL CYRLIN MD

Ophthalmology

3,131

$343K

445
400 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 56%

$110
Average prescription price

Avg: $72

BRET HUGHES MD

Ophthalmology

3,129

$277K

360
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

66%
prescriptions for brand name drugs

Avg: 56%

$89
Average prescription price

Avg: $72

GARY KEOLEIAN M.D.

Ophthalmology

3,100

$246K

722
638 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 56%

$79
Average prescription price

Avg: $72

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank